MetaCap

Heartflow Insider Trades

NASDAQ: HTFLHealth CareMedical/Dental InstrumentsUSD

49.74+2.11 (+4.43%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
26 · $74.93M
Shares bought / sold
0 / 2.39M
Net activity
Net selling $74.9 million

Heartflow insider activity

Over the last 12 months, Heartflow insiders reported 61 transactions on SEC Form 4: 0 open-market purchases and 26 sales. Insiders bought $0 and sold $74.9 million worth of stock, for net insider selling of $74.9 million. The largest seller was Bain Capital Life Sciences Investors, LLC & Bain Capital Life Sciences III General Partner, LLC & Bain Capital Life Sciences Fund III, L.P. & BCLS Fund III Investments GP, LLC & BCLS Fund III Investments, LP, with $58.9 million in reported sales.

The most recent filing shows Rogers Campbell (Chief Medical Officer) reporting a transaction in 12,329 shares at $8.33 on Sep 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put HTFL's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

HTFL insider transactions

Heartflow insider transactions
DateInsiderTypeSharesValueFiling
Sep 18, 2026Verghese VikramChief Financial OfficerSale16,766$850.93KForm 4
Sep 18, 2026Rogers CampbellChief Medical OfficerSale19,682$987.05KForm 4
Sep 18, 2026Rogers CampbellChief Medical OfficerOption exercise850$1.89KForm 4
Sep 18, 2026Rogers CampbellChief Medical OfficerOption exercise12,329$102.70KForm 4
Sep 17, 2026Verghese VikramChief Financial OfficerSale7,579$379.82KForm 4
Sep 15, 2026Verghese VikramChief Financial OfficerSale668$33.41KForm 4
Sep 14, 2026Verghese VikramChief Financial OfficerSale4,593$230.74KForm 4
Sep 11, 2026Farquhar John C.M.Chief Executive OfficerSale3,890$194.50KForm 4
Sep 11, 2026Verghese VikramChief Financial OfficerSale29,714$1.49MForm 4
Sep 10, 2026Farquhar John C.M.Chief Executive OfficerSale35,010$1.63MForm 4
Sep 8, 2026Verghese VikramChief Financial OfficerSale6,640$332.21KForm 4
Sep 3, 2026Verghese VikramChief Financial OfficerSale27,540$1.37MForm 4
Sep 2, 2026Verghese VikramChief Financial OfficerSale5,876$297.33KForm 4
Aug 21, 2026Farquhar John C.M.Chief Executive OfficerSale27,230$1.36MForm 4
Aug 18, 2026Farquhar John C.M.Chief Executive OfficerSale32,676$1.47MForm 4
Aug 17, 2026Rogers CampbellChief Medical OfficerSale9,219$380.10KForm 4
Aug 17, 2026Rogers CampbellChief Medical OfficerOption exercise9,219$175.16KForm 4
Aug 14, 2026Farquhar John C.M.Chief Executive OfficerSale15,560$607.77KForm 4
Aug 10, 2026Farquhar John C.M.Chief Executive OfficerSale22,562$638.73KForm 4
Aug 7, 2026Rogers CampbellChief Medical OfficerTax withholding637$18.36KForm 4
Aug 7, 2026Jones Marie L.Chief Accounting OfficerTax withholding82$2.36KForm 4
Aug 7, 2026Farquhar John C.M.Chief Executive OfficerTax withholding1,904$54.87KForm 4
Aug 7, 2026Verghese VikramChief Financial OfficerTax withholding473$13.63KForm 4
Aug 6, 2026Rogers CampbellChief Medical OfficerTax withholding1,635$44.46KForm 4
Aug 6, 2026Jones Marie L.Chief Accounting OfficerTax withholding486$13.21KForm 4
Aug 6, 2026Farquhar John C.M.Chief Executive OfficerTax withholding5,847$158.98KForm 4
Aug 6, 2026Verghese VikramChief Financial OfficerTax withholding1,537$41.79KForm 4
Jul 30, 2026Farquhar John C.M.Chief Executive OfficerOption exercise9,737$93.28KForm 4
Jul 30, 2026Farquhar John C.M.Chief Executive OfficerOption exercise18,694$41.50KForm 4
Jul 30, 2026Farquhar John C.M.Chief Executive OfficerOption exercise2,789$23.23KForm 4
Jul 27, 2026Verghese VikramChief Financial OfficerOption exercise22,522$50.00KForm 4
Jul 24, 2026Lightcap Jeffrey CDirectorOption exercise47,420$900.98KForm 4
Jul 22, 2026BARABE TIMOTHY CDirectorOption exercise3,710$70.49KForm 4
Jul 21, 2026Verghese VikramChief Financial OfficerOption exercise22,522$50.00KForm 4
Jul 17, 2026BARABE TIMOTHY CDirectorOption exercise5,000$95.00KForm 4
Jul 15, 2026Rogers CampbellChief Medical OfficerSale9,219$237.11KForm 4
Jul 15, 2026Rogers CampbellChief Medical OfficerOption exercise9,219$175.16KForm 4
Jul 10, 2026Farquhar John C.M.Chief Executive OfficerSale22,562$626.10KForm 4
Jul 8, 2026WELDON WILLIAM CDirectorOption exercise17,123$142.63KForm 4
Jul 8, 2026WELDON WILLIAM CDirectorOption exercise17,123$142.63KForm 4
Jul 8, 2026WELDON WILLIAM CDirectorOption exercise17,123$142.63KForm 4
Jun 24, 2026Farquhar John C.M.Chief Executive OfficerSale38,900$1.36MForm 4
Jun 15, 2026Rogers CampbellChief Medical OfficerOption exercise10,000$22.20KForm 4
Jun 10, 2026Farquhar John C.M.Chief Executive OfficerSale22,562$643.02KForm 4
May 18, 2026Rogers CampbellChief Medical OfficerSale9,219$261.27KForm 4
May 18, 2026Rogers CampbellChief Medical OfficerOption exercise9,219$175.16KForm 4
May 11, 2026Farquhar John C.M.Chief Executive OfficerSale22,562$657.01KForm 4
May 7, 2026Farquhar John C.M.Chief Executive OfficerTax withholding1,904$57.08KForm 4
May 7, 2026Verghese VikramChief Financial OfficerTax withholding473$14.18KForm 4
May 7, 2026Rogers CampbellChief Medical OfficerTax withholding637$19.10KForm 4
May 7, 2026Jones Marie L.Chief Accounting OfficerTax withholding82$2.46KForm 4
May 6, 2026Farquhar John C.M.Chief Executive OfficerTax withholding5,300$160.54KForm 4
May 6, 2026Verghese VikramChief Financial OfficerTax withholding1,536$46.53KForm 4
May 6, 2026Rogers CampbellChief Medical OfficerTax withholding1,634$49.49KForm 4
May 6, 2026Jones Marie L.Chief Accounting OfficerTax withholding485$14.69KForm 4
Apr 30, 2026Bain Capital Life Sciences Investors, LLC & Bain Capital Life Sciences III General Partner, LLC & Bain Capital Life Sciences Fund III, L.P. & BCLS Fund III Investments GP, LLC & BCLS Fund III Investments, LP10% OwnerSale56,224$1.69MForm 4
Apr 30, 2026Bain Capital Life Sciences Investors, LLC & Bain Capital Life Sciences III General Partner, LLC & Bain Capital Life Sciences Fund III, L.P. & BCLS Fund III Investments GP, LLC & BCLS Fund III Investments, LP10% OwnerSale892,533$26.04MForm 4
Apr 29, 2026Bain Capital Life Sciences Investors, LLC & Bain Capital Life Sciences III General Partner, LLC & Bain Capital Life Sciences Fund III, L.P. & BCLS Fund III Investments GP, LLC & BCLS Fund III Investments, LP10% OwnerSale797,133$23.41MForm 4
Apr 28, 2026Bain Capital Life Sciences Investors, LLC & Bain Capital Life Sciences III General Partner, LLC & Bain Capital Life Sciences Fund III, L.P. & BCLS Fund III Investments GP, LLC & BCLS Fund III Investments, LP10% OwnerSale254,110$7.75MForm 4
Mar 6, 2026Jones Marie L.Chief Accounting OfficerAward1,661$26.83KForm 4
Mar 6, 2026Verghese VikramChief Financial OfficerAward671$10.84KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related